Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: CIHR Fellowship

Direct Payment

$100,000.00

Towards Precision Diagnostics: Leveraging mitochondrial DNA variation and lactate measures to delineate bipolar disorder pathophysiology

EF 2023-24

Résumé
Bipolar disorder (BD) is a complex and debilitating mood disorder, marked by a variety of symptoms/features that present differently across persons. Compared to the general population, it is associated with greater rates of additional medical conditions, suicide, and death. Early diagnosis is critical to reduce the burden of the illness, however there are currently no objective assessment tools to diagnose BD, making it challenging to detect early in the course of the illness. Although the full biology remains unknown, mitochondria, which play a significant role in energy regulation, have been shown to play a role, at least in some types of BD. Studies have proven that BD is highly heritable, and there are many regions of the genome that have been shown to be associated with BD. However, these studies have largely focused on the genome found in the nucleus of the cell (nuclear DNA) and excluded the genome in the mitochondria (mitochondrial DNA), which encodes genes relevant to mitochondrial function. Another limitation of prior research is the focus on case-control studies, which do not take the complex features of BD into consideration. The proposed work addresses these limitations; We will use two large BD cohorts to examine mitochondria's involvement in BD by assessing genes from the mitochondria and lactate (a marker of mitochondrial function) levels in subjects with various BD features. We will also use the BD features, genetic and lactate data to identify groups within BD that vary in the degree of mitochondrial dysfunction, and we will assess whether the severity of the illness differs across these groups. This work will advance our understanding of the biology of BD and may identify genes in the mitochondrial DNA that can be used as an objective marker to detect BD risk, thus advancing precision diagnostic tools.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Minnesota, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
492894
Name
Melhuish Beaupre Lindsay
Region
Minnesota
Country
United States of America
Orgtype
Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Towards Precision Diagnostics: Leveraging mitochondrial DNA variation and lactate measures to delineate bipolar disorder pathophysiology
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Bipolar Disorder; Medical Comorbidities; Mitochondrial Dna; Pharmacotherapy Exposure; Subphenotypes
Abstract
Bipolar disorder (BD) is a complex and debilitating mood disorder, marked by a variety of symptoms/features that present differently across persons. Compared to the general population, it is associated with greater rates of additional medical conditions, suicide, and death. Early diagnosis is critical to reduce the burden of the illness, however there are currently no objective assessment tools to diagnose BD, making it challenging to detect early in the course of the illness. Although the full biology remains unknown, mitochondria, which play a significant role in energy regulation, have been shown to play a role, at least in some types of BD. Studies have proven that BD is highly heritable, and there are many regions of the genome that have been shown to be associated with BD. However, these studies have largely focused on the genome found in the nucleus of the cell (nuclear DNA) and excluded the genome in the mitochondria (mitochondrial DNA), which encodes genes relevant to mitochondrial function. Another limitation of prior research is the focus on case-control studies, which do not take the complex features of BD into consideration. The proposed work addresses these limitations; We will use two large BD cohorts to examine mitochondria's involvement in BD by assessing genes from the mitochondria and lactate (a marker of mitochondrial function) levels in subjects with various BD features. We will also use the BD features, genetic and lactate data to identify groups within BD that vary in the degree of mitochondrial dysfunction, and we will assess whether the severity of the illness differs across these groups. This work will advance our understanding of the biology of BD and may identify genes in the mitochondrial DNA that can be used as an objective marker to detect BD risk, thus advancing precision diagnostic tools.
Competitiondate
202310
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Melhuish Beaupre, Lindsay
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $100,000~ $0~